Integrilin - direct healthcare professional communication (DHPC)

eptifibatide

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Integrilin (eptifibatide): Discontinuation of manufacturing of Integrilin

Key facts

• Medicine name:
  Integrilin
• Active substance:
  eptifibatide
• Therapeutic area (MeSH):
  • Angina, Unstable
  • Myocardial Infarction
• Regulatory outcome:
  Withdrawal
• DHPC type:
  Medicine shortage
• Human ATC codes:
  B01AC16
• Dissemination date:
  02/11/2023